Research shows beneficial outcome when used before or after system onset
Letters
Feedback from Our Readers
Coding Corner Question
October’s Coding Challenge Medically Unlikely Edits (MUE)
Coding Corner Answer
October’s Coding Answer
Pain in Rheumatoid Arthritis
Out from the shadow of inflammation
Patients Add Power to Research Initiatives
A look at how OMERACT involves people with rheumatic disease in its studies
Naturally Occurring Antibodies May Lead to New RA Therapies
A study published in the Journal of Immunology indicates that naturally occurring antibodies in the human immune system have the capacity to suppress inflammatory responses throughout the body. These antibodies may provide researchers an opportunity to develop new therapies for rheumatoid arthritis (RA) and other inflammatory conditions using similar pathways.
No Clear Connection Between Inflammation & Disease Progression in AS
TNF blockers decrease symptoms but seem to have little impact on structural damage
Research on IL-17 Cytokine May Lead to Novel Therapies for RA
Research in the laboratory of John D. Mountz, MD, PhD, is opening up a whole new field of study in rheumatoid arthritis (RA).
REF’s Campaign to Support RA Research Nears its Initial Funding Target
The REF’s campaign to support RA research nears its initial funding target
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- Next Page »